- Home
- MLKN vs PCRX Comparison
MLKN vs PCRX Comparison
Compare MLKN & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLKN
- PCRX
- Stock Information
- Founded
- MLKN 1905
- PCRX 2006
- Country
- MLKN United States
- PCRX United States
- Employees
- MLKN N/A
- PCRX N/A
- Industry
- MLKN Office Equipment/Supplies/Services
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- MLKN Consumer Discretionary
- PCRX Health Care
- Exchange
- MLKN Nasdaq
- PCRX Nasdaq
- Market Cap
- MLKN 1.4B
- PCRX 1.2B
- IPO Year
- MLKN N/A
- PCRX 2011
- Fundamental
- Price
- MLKN $16.55
- PCRX $22.27
- Analyst Decision
- MLKN
- PCRX Buy
- Analyst Count
- MLKN 0
- PCRX 5
- Target Price
- MLKN N/A
- PCRX $32.40
- AVG Volume (30 Days)
- MLKN 675.8K
- PCRX 494.3K
- Earning Date
- MLKN 09-23-2025
- PCRX 11-05-2025
- Dividend Yield
- MLKN 4.55%
- PCRX N/A
- EPS Growth
- MLKN N/A
- PCRX N/A
- EPS
- MLKN N/A
- PCRX N/A
- Revenue
- MLKN $3,764,100,000.00
- PCRX $705,848,000.00
- Revenue This Year
- MLKN $5.37
- PCRX $7.36
- Revenue Next Year
- MLKN $3.67
- PCRX $10.07
- P/E Ratio
- MLKN N/A
- PCRX N/A
- Revenue Growth
- MLKN 5.37
- PCRX 2.25
- 52 Week Low
- MLKN $15.25
- PCRX $15.92
- 52 Week High
- MLKN $25.96
- PCRX $27.64
- Technical
- Relative Strength Index (RSI)
- MLKN 30.51
- PCRX 24.75
- Support Level
- MLKN $16.40
- PCRX $24.31
- Resistance Level
- MLKN $16.79
- PCRX $26.05
- Average True Range (ATR)
- MLKN 0.65
- PCRX 0.77
- MACD
- MLKN -0.09
- PCRX -0.39
- Stochastic Oscillator
- MLKN 8.78
- PCRX 5.76
About MLKN MillerKnoll Inc.
MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.